The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York : ? The FDA just removed 12 peptides (BPC157, TB500, Epitalon, GHKCu inj., DSIP, MOTSc, Semax, PEGMGF, Melanotan II, LL37, Dihexa, KPV) from Category 2 (donotcompound BPC 157 Wikipedia Analysis: The peptide problem: Hype is outrunning the evidence McMaster News The trend of unproven peptides is spreading through influencers and RFK Jr. allies CNN